Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Unit - With Amersham - Takes in $3.3B for Q3

NEW YORK, Oct. 8 (GenomeWeb News) - General Electric Healthcare contributed total orders of $3.3 billion to the company's reported total revenues of $38 billion for the third quarter ending Sept. 30, up from $33.4 billion for the same period last year, the company said today.


Total orders for the GE Healthcare unit increased 42 percent over the third quarter in 2003, including Amersham, the company said. The company did not specifically break out Amersham's contribution, but said that excluding Amersham, the unit's orders grew 15 percent to $2.3 billion, which would credit Amersham with $0.6 billion in orders, and growth of 27 percent.


Healthcare's total revenues of $3.3 billion compared to $2.3 billion for the year-ago quarter. The unit had net revenue of $503 million for the quarter, compared to $383 billion for the year-ago period.


Healthcare is the London-based business unit that combines Amersham, which was acquired in April in an $11.3 billion transaction, and GE's the company's legacy General Electric Medical Systems. The two entities operate as GE Bio-Science, and GE Health Technologies, respectively, but are considered one unit.


Jeff Immelt, GE's chairman and chief executive officer, in a statement said GE Healthcare has "made excellent progress" in integrating the acquisition.

The company recognizes revenue from sales of goods when a firm sales agreement is in place, delivery has occurred and collectibility of the fixed or determinable sales price is reasonably assured.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.